Influence of gold marker for magnetic resonance imaging during prostate radiotherapy
, , , , , y
04 oct 2018
Acerca de este artículo
Publicado en línea: 04 oct 2018
Páginas: 99 - 101
Recibido: 13 oct 2017
Aceptado: 20 jun 2018
DOI: https://doi.org/10.2478/pjmpe-2018-0013
Palabras clave
© 2018 Osamu Tanaka et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Gold markers (GM) are increasingly used for CT and MRI registration during in intensity-modulated radiation therapy for prostate cancer. Additionally, diffusion-weighted imaging has been adopted to measure the effects of radiotherapy for prostate cancer, similar to tests of blood prostate-specific antigen levels. As diffusion-weighted imaging (DWI) is often affected by a magnetic component, we evaluated the influence of GM on the Diffusion weighted images in three cases. We found that the size range of signal void of GM in MRI was 2–5 mm. We conclude that a GM would not affect the quality of DWI in daily practice.